Skip to main content
. 2014 Feb 18;82(7):607–613. doi: 10.1212/WNL.0000000000000118

Figure 2. Fat metabolism.

Figure 2

(A) Plasma palmitate concentration, (B) plasma free fatty acid (FFA) concentration, (C) palmitate oxidation, and (D) total fatty acid oxidation (FAO) at rest (gray) and during exercise at 50% to 60% of maximal oxygen uptake capacity (V̇o2max) (black) without and with bezafibrate (green) in 10 patients with carnitine palmitoyltransferase II (n = 5) and very long-chain acyl-CoA dehydrogenase (n = 5) deficiencies. Values are mean ± standard error (SE). *p < 0.05 rest vs exercise; §p < 0.05 placebo vs bezafibrate. Dotted line indicates the mean fatty acid/palmitate oxidation at the 40th minute of exercise in 7 healthy controls exercising at 50% to 60% of V̇o2max, and the shaded area is ±SE.